The α-LGR5 that we have developed has excellent characteristics for serving as an effective ADC: the antibody has high affinity and specificity for LGR5+ cancer cells, is extremely rapidly internalized when bound to LGR5 (<5 minutes rate of internalization) and is transported to the lysosomal compartment [22, 44]. Here, LGR5 is linked to cancer.